Pharmalot Ed Silverman STAT Plus: Pharmalittle: EU fines Illumina $475M for closing Grail deal; life-threatening lead poisoning antidote in short supply
The Obesity Revolution Megan Molteni STAT Plus: How the new weight loss drugs could upend our understanding of craving, desire, and addiction
Biotech Damian Garde, Andrew Joseph and Elaine Chen STAT Plus: What to know about this summer’s landmark Wegovy heart health study
Biotech Matthew Herper STAT Plus: With savvy bets, a dynamic duo makes Eli Lilly one of pharma’s biggest success stories
Exclusive Nicholas Florko STAT Plus: Novo Nordisk bought prescribers over 450,000 meals and snacks to promote drugs like Ozempic
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Novavax’s CEO promises a turnaround & how Lilly roiled the obesity market
Pharma Elaine Chen STAT Plus: After late start, Eli Lilly has the momentum in battle for $30 billion weight loss market
Health Tech Lizzy Lawrence STAT Plus: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?
Biotech Andrew Joseph STAT Plus: U.K. agency declines to recommend Eli Lilly’s Mounjaro for type 2 diabetes
Health Elaine Chen STAT Plus: Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug in small study
Health Elaine Chen STAT Plus: Ozempic 3.0? Lilly’s ‘triple-G’ drug shows biggest weight loss yet in mid-stage trial
Pharmalot Ed Silverman and Elaine Chen STAT Plus: STAT-Harris Poll: Nearly half of U.S. adults would spend $100 a month for Ozempic, other weight loss drugs
Health Elaine Chen STAT Plus: Lilly’s obesity pill cuts 15% of weight at highest dose in mid-stage trial
Health Elaine Chen Diabetes will be ‘a defining disease of this century’ as global cases are set to surpass one billion by 2050
Pharmalot Ed Silverman STAT Plus: Novo Nordisk sues spas and clinics for selling versions of Wegovy and Ozempic for weight loss
Health Brittany Trang and Elaine Chen AMA asks doctors to de-emphasize use of BMI in gauging health and obesity
The Obesity Revolution Julia Belluz and J. Emory Parker Here’s why obesity grew so quickly worldwide, and where that’s starting to change
Health H Conley Studies show top surgery is safe for fat patients, but some surgeons still mandate weight loss
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA
Health Elaine Chen STAT Plus: Novo Nordisk pauses ads for weight loss drug Wegovy as it struggles to meet demand
Pharma Elaine Chen STAT Plus: In small study, weight loss drug boosts immune cells that help fight cancer
Pharma Ambar Castillo STAT Plus: ‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Lilly’s Alzheimer’s success, a milestone FDA approval, & Moderna’s shrinking business